Skip to content

Trial Comparing Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings

A Multi-Center, Prospective, Randomized Trial Comparing the Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02725788
Enrollment
247
Registered
2016-04-01
Start date
2014-09-30
Completion date
2015-05-31
Last updated
2024-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Brief summary

A multi-center randomized control trial comparing the dressing wear times of two different transparent film dressings when used to secure peripheral intravenous catheters of hospitalized adult patients.

Detailed description

A multi-center, prospective, randomized control trial comparing the dressing wear time, complication rates and cost of two different transparent film dressing when used as intended for peripheral intravenous catheter site protection and securement in five U.S. hospitals.

Interventions

DEVICENew PIV Dressing

A commercially available breathable, transparent film dressing with a soft-cloth border, notch and securement tape strip. The dressing system is used in the study to cover a peripheral intravenous catheter insertion site and secure the catheter. Dressing system is to remain in place until the PIV catheter is discontinued which is anticipated to be 72 hours. The dressing and PIV site will be observed daily. If dressing excessively lifts from the skin, the dressing system will be replaced with the same, assigned dressing system. The number of dressing replacements and the duration of wear will be measured while the same study PIV catheter dwells, an average of 72 hours during the subject's hospitalization.

DEVICEStandard PIV Dressing

A commercially available breathable, transparent film dressing used with a one inch width piece of Transpore™ medical tape. The dressing system is used in the study to cover a peripheral intravenous catheter insertion site and secure the catheter. Dressing system is to remain in place until catheter is discontinued which is anticipated to be 72 hours. The dressing and PIV site will be observed daily. If dressing excessively lifts from the skin, the dressing system will be replaced with the same, assigned dressing system. The number of dressing replacements and the duration of wear will be measured while the same study PIV catheter dwells, an average of 72 hours during the subject's hospitalization.

Sponsors

3M
CollaboratorINDUSTRY
Solventum US LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. At least 18 years of age, or of consenting age; 2. Admitted or going to be admitted to the hospital; 3. Requires peripheral IV therapy (catheter) for an anticipated 72 hours or longer; 4. Has an insertion site in the forearm or hand free of phlebitis, infiltration, dermatitis, burns, lesions or tattoos; 5. Demonstrates cooperation with a catheter insertion and the securement protocol; and 6. Patient or legally authorized representative is willing and able to provide written informed consent and authorization for use and disclosure of Protected Health Information

Exclusion criteria

1. Is a current participant or a past participant in this study; 2. If the subject already has a functioning PIV in place, not requiring a replacement catheter 3. If the study PIV catheter site will be placed below an old infusion site; 4. If the study PIV site needs to be immobilized with a splint or other device; 5. Has a documented or a known allergy or sensitivity to a medical adhesive product such as transparent film adhesive dressings, tapes, or liquid skin protectants; 6. Requires the application of a gauze pad, a topical ointment or solution under the dressing in addition to the prep(s) required in the protocol; 7. Will require a power injection through the study PIV catheter for a radiologic procedure during participation in this study; 8. Will require a numbing agent prior to PIV insertion; or 9. Will require the use of ultrasound for the PIV catheter insertion.

Design outcomes

Primary

MeasureTime frameDescription
Dressing Wear TimeDressing wear time was assessed daily and 8 month dressing wear data are presentedDressing wear time is the time from dressing application to removal, i.e. catheter no longer needed or catheter-related complication occurs (remove dressing and catheter) OR excessive dressing lift requiring dressing replacement.

Countries

United States

Participant flow

Recruitment details

From September 24, 2014 to May 12, 2015 at five U.S. hospitals

Participants by arm

ArmCount
New Dressing
Bordered, notched film dressing sized to cover, secure peripheral venous (PIV) catheters
122
Standard PIV Dressing
Film adhesive dressing used with medical grade tape and sized to cover, secure peripheral (PIV) catheters
122
Total244

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up11
Overall StudyProtocol Violation01

Baseline characteristics

CharacteristicNew DressingStandard PIV DressingTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
45 Participants44 Participants89 Participants
Age, Categorical
Between 18 and 65 years
77 Participants78 Participants155 Participants
Age, Continuous60 years60 years60 years
PIV catheter insertion location
Hand
74 Participants71 Participants145 Participants
PIV catheter insertion location
Lower Forearm
22 Participants20 Participants42 Participants
PIV catheter insertion location
Mid Forearm
16 Participants15 Participants31 Participants
PIV catheter insertion location
Upper Forearm
10 Participants16 Participants26 Participants
Region of Enrollment
United States
122 participants122 participants244 participants
Sex: Female, Male
Female
60 Participants58 Participants118 Participants
Sex: Female, Male
Male
62 Participants64 Participants126 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1230 / 124
serious
Total, serious adverse events
0 / 1230 / 124

Outcome results

Primary

Dressing Wear Time

Dressing wear time is the time from dressing application to removal, i.e. catheter no longer needed or catheter-related complication occurs (remove dressing and catheter) OR excessive dressing lift requiring dressing replacement.

Time frame: Dressing wear time was assessed daily and 8 month dressing wear data are presented

Population: All subjects randomized except three subjects who either failed to have a study dressing applied or whom could not have the primary endpoint ascertained.

ArmMeasureValue (MEDIAN)
New DressingDressing Wear Time2.1 Days
Standard PIV DressingDressing Wear Time2.1 Days

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026